NeuroGenesis, Inc. manufactures and markets nutritional supplements of a particular type. The company is headquartered in League City, Texas. The company went IPO on 2001-10-05. The Company’s products include Neu-Becalm'd 90 Capsules and Neu-Relieve 90 Capsules. The Company’s nutritional supplements are manufactured and packaged in one of its two facilities located across the United States.
NEUN stock price ended at $0 on Friday, after rising NaN%
On the latest trading day Dec 26, 2025, the stock price of NEUN rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 34.7K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 41.0K shares were traded, amounting to a market value of approximately --.
NEUN Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 7
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
NEUN currently exhibits 0 buy signals and 0 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.
Bullish/Bearish Signals for NEUN
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for NEUN. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to NEUN?
According to technical analysis, NeuroGenesis Inc has an aggregate signal of Neutral. NeuroGenesis Inc has 0 Buy signals, 7 Neutral Signals and 0 sell signals.
What is the RSI for NeuroGenesis Inc?
The RSI for NeuroGenesis Inc is currently NaN, indicating a neutral condition
What is NeuroGenesis Inc price for the next 12 months?
NeuroGenesis Inc NEUN price for the next 12 months is estimated at $0.
How high is NeuroGenesis Inc expected to go?
According to wall street analysts, NeuroGenesis Inc is expected to reach a high forecast of $0.